This finding is consistent with prior studies demonstrating upregulation of oncogenic WT1 isoforms known to be overexpressed in solid tumors and leukemias [24,66–68] and associated with multiple oncogenic functions including promotion of proliferation, antiapoptotic activity, angiogenesis and metastases [32,33,66]. This evidence concerns the gene WT1 and leukemia.